Skip to content

BRAIN SCIENTIFIC INC.: 10-Q filed 2022-11-14

What BRAIN SCIENTIFIC INC. reported in its quarterly report filed 2022-11-14 (fiscal Q3 2022): 47 published measures, 136 facts as tagged in accession 0001213900-22-071879.

This filing

Form
10-Q (quarterly report)
Filed
2022-11-14
Fiscal period
fiscal Q3 2022
Accession
0001213900-22-071879 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BRAIN SCIENTIFIC INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2022-09-3014,021,816USD
At 2021-12-3113,375,216USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2022-09-306,835,144USD
At 2021-12-3114,070,149USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2022-09-307,186,672USD
At 2021-12-31-694,933USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,436,753USD92
2022-01-01 to 2022-09-30-9,110,360USD273
2022-04-01 to 2022-06-30-2,513,669USD91
2022-01-01 to 2022-03-31-2,159,938USD90
2021-07-01 to 2021-09-30-1,800,839USD92
2021-01-01 to 2021-09-30-3,575,585USD273
2021-04-01 to 2021-06-30-1,120,742USD91
2021-01-01 to 2021-03-31-654,004USD90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-4,691,693USD273
2021-01-01 to 2021-09-30-2,791,561USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-01-01 to 2022-09-3027,466USD273
2021-01-01 to 2021-09-3038,339USD273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2022-07-01 to 2022-09-3011,432USD92
2022-01-01 to 2022-09-30209,484USD273
2021-07-01 to 2021-09-305,275USD92
2021-01-01 to 2021-09-3014,482USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-01-01 to 2022-09-306,018,610USD273
2021-01-01 to 2021-09-303,469,982USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-27,466USD273
2021-01-01 to 2021-09-30-641,406USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2022-09-30-31,389,283USD
At 2021-12-31-22,278,923USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2022-07-01 to 2022-09-30105,401,858shares92
2022-01-01 to 2022-09-3072,516,279shares273
2021-07-01 to 2021-09-3029,520,454shares92
2021-01-01 to 2021-09-3029,520,454shares273

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2022-07-01 to 2022-09-30105,401,858shares92
2022-01-01 to 2022-09-3072,516,279shares273
2021-07-01 to 2021-09-3029,520,454shares92
2021-01-01 to 2021-09-3029,520,454shares273

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.04USD/shares92
2022-01-01 to 2022-09-30-0.13USD/shares273
2021-07-01 to 2021-09-30-0.06USD/shares92
2021-01-01 to 2021-09-30-0.12USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-0.04USD/shares92
2022-01-01 to 2022-09-30-0.13USD/shares273
2021-07-01 to 2021-09-30-0.06USD/shares92
2021-01-01 to 2021-09-30-0.12USD/shares273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2022-09-30124,740USD
At 2021-12-31122,979USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,018,087USD92
2022-01-01 to 2022-09-30-8,105,195USD273
2021-07-01 to 2021-09-30-1,732,482USD92
2021-01-01 to 2021-09-30-3,505,349USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2022-09-302,452,737USD
At 2021-12-311,131,774USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2022-07-01 to 2022-09-30703,232USD92
2022-01-01 to 2022-09-302,589,486USD273
2021-07-01 to 2021-09-3068,357USD92
2021-01-01 to 2021-09-30182,574USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2022-09-306,805,994USD
At 2021-12-314,343,509USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2022-09-30913,184USD
At 2021-12-31913,184USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2022-09-3010,343,538USD
At 2021-12-3110,920,577USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2022-09-305,971USD
At 2021-12-3116,922USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2022-07-01 to 2022-09-304,025,461USD92
2022-01-01 to 2022-09-308,165,978USD273
2021-07-01 to 2021-09-301,733,614USD92
2021-01-01 to 2021-09-303,511,991USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2022-09-30126,132USD
At 2021-12-31146,090USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-307,374USD92
2022-01-01 to 2022-09-3060,783USD273
2021-07-01 to 2021-09-301,132USD92
2021-01-01 to 2021-09-306,642USD273

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2022-07-01 to 2022-09-3056,684USD92
2022-01-01 to 2022-09-30224,405USD273
2021-07-01 to 2021-09-3048,282USD92
2021-01-01 to 2021-09-30147,324USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2022-07-01 to 2022-09-3056,684USD92
2022-01-01 to 2022-09-30224,405USD273
2021-07-01 to 2021-09-3048,282USD92
2021-01-01 to 2021-09-30147,324USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2022-09-30105,401,858shares
At 2021-12-3150,217,308shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2022-09-302,029,839USD
At 2021-12-31785,363USD
At 2021-09-30105,958USD
At 2020-12-3168,943USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2022-09-3038,474,527USD
At 2021-12-3121,537,763USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2022-09-30-3,974USD
At 2021-12-31-3,990USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2022-09-307,186,672USD
At 2022-06-308,996,516USD
At 2022-03-31-2,488,880USD
At 2021-12-31-694,933USD
At 2021-09-30-5,583,173USD
At 2021-06-30-3,782,334USD
At 2021-03-31-2,661,592USD
At 2020-12-31-2,007,588USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2022-09-30107,617USD
At 2021-12-31191,702USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2022-09-30110,162USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2022-09-3091,686USD
At 2021-12-3165,982USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2022-09-3010,343,538USD
At 2021-12-3110,920,577USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2022-09-302,653,036USD
At 2021-12-312,987,264USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2022-09-3011,352USD
At 2021-12-3146,170USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,436,753USD92
2022-01-01 to 2022-09-30-9,110,360USD273
2021-07-01 to 2021-09-30-1,800,839USD92
2021-01-01 to 2021-09-30-3,575,585USD273

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-4,435,415USD92
2022-01-01 to 2022-09-30-9,110,344USD273
2021-07-01 to 2021-09-30-1,800,839USD92
2021-01-01 to 2021-09-30-3,575,585USD273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2022-07-01 to 2022-09-301,083,778USD92
2022-01-01 to 2022-09-303,628,337USD273
2021-07-01 to 2021-09-301,177,077USD92
2021-01-01 to 2021-09-302,292,775USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2022-01-01 to 2022-09-30602,744USD273
2021-01-01 to 2021-09-3019,736USD273

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2022-07-01 to 2022-09-30577,039USD92
2022-01-01 to 2022-09-30192,365USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2022-07-01 to 2022-09-30-418,666USD92
2022-01-01 to 2022-09-30-1,005,165USD273
2021-07-01 to 2021-09-30-68,357USD92
2021-01-01 to 2021-09-30-70,236USD273

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2022-01-01 to 2022-09-30106,039USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-10,951USD273
2021-01-01 to 2021-09-302,529USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2022-01-01 to 2022-09-30-19,958USD273
2021-01-01 to 2021-09-3062,239USD273

Inspect the source

Entity
BRAIN SCIENTIFIC INC. / CIK 0001662382
Captured
SEC response SHA-256
65e17d0e702756b77c9b53df1319f658664a8db70c1434c3f7959f007a39e761

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001662382.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))